Crescent Biopharma, Inc. (CBIO) Dividend Yield, History & Forecast
Crescent Biopharma, Inc. (CBIO) is a Biotechnology company in the Healthcare sector listed on the NASDAQ Capital Market. market capitalization is approximately $535M.
Frequently Asked Questions about Crescent Biopharma, Inc. (CBIO)
Is Crescent Biopharma, Inc. a Dividend Aristocrat?▾
Dividend Aristocrat status requires an S&P 500 listing and 25 or more consecutive years of dividend increases. See our curated Dividend Aristocrats list for the full roster.
What sector is Crescent Biopharma, Inc. in?▾
Crescent Biopharma, Inc. (CBIO) operates in the Healthcare sector, specifically the Biotechnology industry.